What the research reports
View evidenceRat and swine pharmacology characterised ipamorelin as a selective growth-hormone secretagogue.
Raun et al., European Journal of Endocrinology, 1998 · PubMed
Image 01 / 01Research compound
Ipamorelin
Selective GHS-R1a agonist — GH release · Preclinical
Research compoundCA$95.00
Select variant
Ipamorelin/
CA$95.00
Where the evidence comes from
View evidenceIpamorelin findings shown here come from cited rat and swine pharmacology.
Raun et al., European Journal of Endocrinology, 1998 · PubMed
What's still open
Ipamorelin findings shown here remain limited to the cited rat and swine studies.
Raun et al., European Journal of Endocrinology, 1998 · PubMed
